| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |